Medicine
Sulindac 150 mg tablet
Sulindac 150 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Sulindac
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 50 tablets, 250 tablets and 12 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaEpic PharmaActavis PharmaBlu PharmaceuticalsPD-Rx Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M01AB02 Sulindac
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 3 April 1990
- Identifiers
- RxCUI 198238, 198239DailyMed set ID d8b9d517-5dd4-4c6b-8aa0-736bce87e7b4, a47e4259-d44b-4b7b-b517-841cb6840982, 96c73bd2-4577-487d-a642-bd8f91e94c3a +2NDC 0591-5661, 53489-478, 42806-018 +2Application ANDA071891, ANDA072050, ANDA072710
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle, plastic | 53489-478-01 | Sun Pharmaceutical IndustriesIndia | 4 September 2009 |
| 50 tablet in 1 bottle, plastic | 53489-478-02 | Sun Pharmaceutical IndustriesIndia | 4 September 2009 |
| 250 tablet in 1 bottle, plastic | 53489-478-03 | Sun Pharmaceutical IndustriesIndia | 4 September 2009 |
| 500 tablet in 1 bottle, plastic | 53489-478-05 | Sun Pharmaceutical IndustriesIndia | 4 September 2009 |
| 60 tablet in 1 bottle, plastic | 53489-478-06 | Sun Pharmaceutical IndustriesIndia | 4 September 2009 |
| 1000 tablet in 1 bottle, plastic | 53489-478-10 | Sun Pharmaceutical IndustriesIndia | 4 September 2009 |
| 100 tablet in 1 bottle, plastic | 0591-5661-01 | Actavis Pharma | 3 April 1990 |
| 500 tablet in 1 bottle, plastic | 0591-5661-05 | Actavis Pharma | 3 April 1990 |
| 100 tablet in 1 bottle | 24658-770-01 | Blu Pharmaceuticals | 14 November 2016 |
| 500 tablet in 1 bottle | 24658-770-05 | Blu Pharmaceuticals | 14 November 2016 |
| 100 tablet in 1 bottle | 42806-018-01 | Epic Pharma | 25 January 2010 |
| 500 tablet in 1 bottle | 42806-018-05 | Epic Pharma | 25 January 2010 |
| 1000 tablet in 1 bottle | 42806-018-10 | Epic Pharma | 25 January 2010 |
| 100 tablet in 1 bottle, plastic | 72789-373-01 | PD-Rx Pharmaceuticals | 19 January 2024 |
| 500 tablet in 1 bottle, plastic | 72789-373-82 | PD-Rx Pharmaceuticals | 25 January 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 27 September 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sulindac
Clinical summary
Sulindac is a nonsteroidal anti-inflammatory drug indicated for acute or long-term use in the relief of signs and symptoms of the following. It is available as tablets for oral use. MedsAcross supplies Sulindac for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SulindacFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SULINDAC prescribing information (Blu Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Sulindac 150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.